Patient Focused Treatment of Gynecologic Cancers - 2021 Annual Meeting
This panel of speakers examine four different aspects of patient oriented factors that will allow the practicing radiation oncologist to better recommend, direct, and evaluate the results of therapy for women with gynecologic cancers. The speakers examine the differences in access to care and the disparities that different populations face, the barriers that prevent access, and potential means to mitigate them. The panel describes the use of molecular and imaging factors that can determine the differential response to radiation therapy in women with cervical cancer, laying the ground for treatment intensification or de-intensification for future clinical investigations. Then it reports on the use of intra-treatment imaging with MRI-Linacs to better customize and adapt to individual changes in anatomy. Finally speakers describe the use of patient-reported outcomes in clinical trials, and how they may differ from physician reported ones.
This activity is available from February 14, 2022, through 11:59 p.m. Eastern time on February 13, 2025.
This activity was originally recorded at ASTRO’s 2021 Annual Meeting, October 24-27th.
The activity is designed to meet the interests of radiation oncologists, radiation oncology residents, radiation physicists, radiation therapists, radiation dosimetrists, radiation biologists.
Upon completion of this activity, participants should be able to:
- Describe the current disparities experienced by different populations, and the means to which we might mitigate them.
- Describe state of the art imaging and molecular determinants of response in women with cervical cancer.
- Describe the use and potential benefits of online MRI evaluation of treatment response with MRI-Linacs in gynecologic cancers.
- Mark E. Bernard, MD, University of Pittsburgh Cancer Institute has no financial relationships with a commercial interest.
- Tracey Schefter, MD, Department of Radiation Oncology, University of Colorado School of Medicine has no financial relationships with a commercial interest.
- Haley Moss, MD, Duke University Medical Center has no financial relationships with a commercial interest.
- Stephanie Markovina, MD, PhD, Washington University School of Medicine, Department of Radiation Oncology has no financial relationships with a commercial interest.
- Lorraine Portelance, Department of Radiation Oncology, University of Miami, Sylvester Comprehensive Cancer Center serves as a committee member at NRG: Cervix Committee and serves as an Advisory Board Member at Sirtex.
- Dana Chase, MD, Arizona Oncology Associates - East Valley, receives compensation from AstraZeneca, Tesaro, Inc., Genetech, Clovis, Takeda Pharmaceuticals, International, Merck Sharp & Dohme.
- Junzo Chino, MD, Duke University Medical Center has investment interest from NanoScint.
The person(s) above served as the developer(s) of this activity. Additionally, the Education Committee had control over the content of this activity. All relevant relationships have been mitigated.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.
ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.
- 1.25 Certificate of AttendanceThis activity was designated for 1.25 AMA PRA Category 1 Credit™.
- 1.25 SA-CME
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.
The American Society for Radiation Oncology (ASTRO) designates this for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.25 self-assessment credits.
ASTRO members must log in to the ASTRO website to view and receive the discounted member rate.
No refunds, extensions, or substitutions will be made for those participants who, for any reason, have not completed the course by the end of the qualification date. The qualification date for each course is listed in the course catalog on the ASTRO website under availability.
Participants using ASTRO's online courses to satisfy the requirement of a Maintenance of Certification (MOC) program should verify the number, type and availability dates of any course before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased courses that do not align with their MOC requirement.
The course and its materials will only be available on the ASTRO website for that 3 year period regardless of purchase date. At the expiration of the qualification, participants will no longer have access to the course or its materials. ASTRO reserves the right to remove a course before the end of its qualification period.
One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.